European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Safe and Sensible Tissue Graspers for Pediatric and (Mini-)Laparoscopic Surgery

Descripción del proyecto

Mejoras tecnológicas en cirugía laparoscópica

Cada año se llevan a cabo en todo el mundo más de quince millones de intervenciones quirúrgicas laparoscópicas. Sin embargo, parecen tener una incidencia de complicaciones un 4 % superior a la obtenida con intervenciones abiertas. Estos datos se atribuyen a los problemas con las pinzas quirúrgicas, que no informan sobre la fuerza ejercida, lo que obliga a los cirujanos a pinzar repetidamente y puede causar lesiones en los tejidos. En el proyecto SensAtouch Grasper, financiado con fondos europeos, se ha desarrollado una pinza novedosa, más sensible y rentable, que funciona de forma similar a muchos instrumentos punteros. El uso de estas pinzas aumentará la seguridad y la eficacia de los procedimientos laparoscópicos y reducirá los costes de atención sanitaria asociados.

Objetivo

Laparoscopic surgery is the most common surgical intervention with over 15 million procedures performed annually worldwide. Most recently, the Dutch Healthcare Inspectorate shocked the medical community when discovering the risk of patient complications is 2-4% higher per laparoscopic operation as compared to its outdated equivalent, open abdominal surgery. Patient post-operative complications are the most costly of medical errors, increasing hospital costs by € 15 Billion per year in EU/US, with €6 Billion directly contributed by 5 laparoscopic procedures. Clinical research acknowledges that state-of-the-art graspers lack force feedback capabilities, which is responsible for accidental tissue trauma, a primary factor of post-operative complications. In fact, it is observed that 38% of all grasper movements are unsuccessful, meaning the surgeon is unable to perform the desired action without repeated clamping, slip, or obvious tissue trauma. MMI is commercializing a new line of force feedback surgical graspers that replaces the root technology of state-of-the-art to address the immediate clinical needs, while converging onto three business trends in the market. The SensAtouch grasper is more sensitive, cost effective, and can be diametrically miniaturised without loss of performance. The SensAtouch technology operates on the same working principles as state-of-the-art instruments and is attachable onto the vast majority of commercially-available grasper handles. Therefore, this innovation will disrupt the laparoscopic device market by enhancing safety and effectiveness, while maintaining operating room dynamics and medical device supply chains. The SensAtouch grasper can be procured without added costs to the hospital, while reducing post-operative complication costs up to € 6 Billion in the EU/US annually. The entry market of pediatric surgery opens direct access into the mini- and general laparoscopic device markets valued globally at € 8.9 billion in 2017.

Convocatoria de propuestas

H2020-EIC-SMEInst-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-SMEInst-2018-2020-1

Régimen de financiación

SME-1 - SME instrument phase 1

Coordinador

MILTON MEDICAL INNOVATIONS BV
Aportación neta de la UEn
€ 50 000,00
Dirección
AMPERESTRAAT 214
2563 ZZ 'S-GRAVENHAGE
Países Bajos

Ver en el mapa

Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.

Región
West-Nederland Zuid-Holland Agglomeratie ’s-Gravenhage
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 71 429,00